Respiratory syncytial virus lower respiratory tract infection in a pediatric liver transplant recipient treated with oral ribavirin

Megan Keck, Cezarina Mindru, Andre C. Kalil, David F. Mercer, Diana F. Florescu

Research output: Contribution to journalArticlepeer-review

5 Scopus citations

Abstract

The mainstay of therapy for RSV disease is supportive care, although aerosolized ribavirin has been used to treat infants and young children with severe lower respiratory tract infections. Aerosolized ribavirin has adverse effects, high cost and teratogenic potential. We report the case of a pediatric liver transplant recipient diagnosed with lower respiratory RSV infection, who was successfully treated with oral ribavirin.

Original languageEnglish (US)
Pages (from-to)E348-E351
JournalPediatric Transplantation
Volume16
Issue number8
DOIs
StatePublished - Dec 2012

Keywords

  • pediatric liver transplantation
  • respiratory syncytial virus
  • treatment

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Transplantation

Fingerprint Dive into the research topics of 'Respiratory syncytial virus lower respiratory tract infection in a pediatric liver transplant recipient treated with oral ribavirin'. Together they form a unique fingerprint.

Cite this